- Registration Closed
Emergence of multiplex technology in immunohistochemistry (IHC) space including immunofluorescence (IF) significantly improved the capability to detect multiple molecules simultaneously in tissues and in isolated cells. This technology enables visualization of target molecules at a higher resolution even for targets that are of low abundance. Multiplexing provides a comprehensive understanding of the presence or absence of target molecules, captures complex expression patterns of biomarkers in research and clinical specimens, offers an enhanced understanding of target marker expressions in tissues and single cells. This workshop focuses on multiplex methodology and test evaluation, development of reliable tests, data analysis, advantages and disadvantages of multiplexing in research and clinical use, and a discussion on test validation. This intermediate level interactive workshop offers an in-depth understanding of multiplexing for research and clinical applications.
CEUs: This histology course is worth 1 continuing education credit. Course is available for 365 days from date of purchase.
Aniruddha Ganguly, PhD, QIHC(ASCP)
National Cancer Institute/ NIH
Dr. Aniruddha Ganguly earned his Ph.D. in Cell Biology and trained in tumor biology. He has expertise in mechanisms of tumor development and metastasis, tumor microenvironment, biospecimen processing, cancer biomarkers, clinical assay development, cancer diagnostics, and molecular analysis technologies for cancer research. Before joining the National Cancer Institute (NCI) as a Program Director, Dr. Ganguly served as an Assistant Professor at Harvard Medical School/Harvard University for many years directing and conducting cancer research, and teaching MD/DMD students. He was supervisor of the IHC Clinical Services Laboratory of the department of Pathology at Massachusetts General Hospital, Boston. At the NCI, he has responsibilities for providing guidance to the planning, development, implementation, and evaluation of assigned biomedical research programs including, molecular diagnostic technologies, Extracellular RNA Consortium, brain tumor research and NCI's brain tumor clinical trial program. He has a strong emphasis in training, mentoring, and promoting young investigators involved in cancer research.
Key:
Complete
Next
Failed
Available
Locked